A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas

Summary

This is a First-in-Human Phase I trial of ATG-101 in Patients with Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas.

Timeline

Start

2021-12-15

Primary completion

2025-01-31

Completion

2025-01-31

Outcome

Outcome not reported

Stopped (Business): “It is due to the recent changes in the competitor landscape and strategic consideration”

Drugs

Indications